Almelo is a 45 year old company with 3 manufacturing sites focused on novel chemistry applications for generic pharmaceuticals as well as mid to late-stage clinical assets. Our facilities are approved by global regulatory authorities including US FDA EDQM, PMDA, WHO Geneva. We are also PSCI approved and Ecovadis rated for EHS.

Type of Drugs Manufactured:

Small Molecule

CDMO Services:

Drug Substance Manufacturing (API);Research & Development

No. of Manufacturing Facilities:

3-5

Facilities Locations:

South Asia

Regulatory Approvals for facilities:

FDA (United States);EMA (Europe);ISO;GMP;PMDA (Japan);NMPA (China)